We Develop Polyclonal Antibodies to Assist the Pharmaceutical and Food Producers to Achieve an Effective Product Based On a Nature-Friendly Primary Ingredient
Our founder came close to the idea of producing
biotechnology products at Royan Biotechnology
Research Institute.
Our founder came close to the idea of producing
biotechnology products at Royan Biotechnology
Research Institute.
In the first laboratory experiment with polyclonal
antibodies, they succeeded in inhibiting the growth
of E.coli bacteria.
In the first laboratory experiment with polyclonal
antibodies, they succeeded in inhibiting the growth
of E.coli bacteria.
In the first invivo test, they succeeded in producing an
immunotherapy drug with polyclonal antibody to treat
diarrhea in calves.
In the first invivo test, they succeeded in producing an
immunotherapy drug with polyclonal antibody to treat
diarrhea in calves.
The development of knowledge-based drug and
supplements is associated with the establishment of
technology in the field of biotechnology.
The development of knowledge-based drug and
supplements is associated with the establishment of
technology in the field of biotechnology.
Obtaining a research grant for the development of technical
knowledge and the production of immunotherapy drugs
Obtaining a research grant for the development of technical
knowledge and the production of immunotherapy drugs
By designing pharmaceutical products and supplements, it won
the award for the best technological project of the country in
2016 and the best designed products of the University
Educational, Cultural and Research Center (ACECR) in 2017.
By designing pharmaceutical products and supplements, it won
the award for the best technological project of the country in
2016 and the best designed products of the University
Educational, Cultural and Research Center (ACECR) in 2017.
Success in a highly efficient process of extraction and processing while preserving the structure and function of antibodies.
Success in a highly efficient process of extraction and
processing while preserving the structure and function of
antibodies.
Royan Biotechnologist Immuno company officially registered
product development and sales units.
Royan Biotechnologist Immuno company officially registered
product development and sales units.
Establishment at the location of Royan Center technology
companies in Royan Innovative Technologies Acceleration
and Commercialization Center (RITAC)
Establishment at the location of Royan Center technology
companies in Royan Innovative Technologies Acceleration
and Commercialization Center (RITAC)
Research and development in antibody therapy of
Inflammatory bowel disease
Research and development in antibody therapy of
Inflammatory bowel disease
Our founder came close to the idea of producing
biotechnology products at Royan Biotechnology
Research Institute.
Our founder came close to the idea of producing
biotechnology products at Royan Biotechnology
Research Institute.
In the first laboratory experiment with polyclonal
antibodies, they succeeded in inhibiting the growth
of E.coli bacteria.
In the first laboratory experiment with polyclonal
antibodies, they succeeded in inhibiting the growth
of E.coli bacteria.
In the first invivo test, they succeeded in producing an
immunotherapy drug with polyclonal antibody to treat
diarrhea in calves.
In the first invivo test, they succeeded in producing an
immunotherapy drug with polyclonal antibody to treat
diarrhea in calves.
The development of knowledge-based drug and
supplements is associated with the establishment of
technology in the field of biotechnology.
The development of knowledge-based drug and
supplements is associated with the establishment of
technology in the field of biotechnology.
Obtaining a research grant for the development of technical
knowledge and the production of immunotherapy drugs
Obtaining a research grant for the development of technical
knowledge and the production of immunotherapy drugs
By designing pharmaceutical products and supplements, it won
the award for the best technological project of the country in
2016 and the best designed products of the University
Educational, Cultural and Research Center (ACECR) in 2017.
By designing pharmaceutical products and supplements, it won
the award for the best technological project of the country in
2016 and the best designed products of the University
Educational, Cultural and Research Center (ACECR) in 2017.
Success in a highly efficient process of extraction and processing while preserving the structure and function of antibodies.
Success in a highly efficient process of extraction and
processing while preserving the structure and function of
antibodies.
Royan Biotechnologist Immuno company officially registered
product development and sales units.
Royan Biotechnologist Immuno company officially registered
product development and sales units.
Establishment at the location of Royan Center technology
companies in Royan Innovative Technologies Acceleration
and Commercialization Center (RITAC)
Establishment at the location of Royan Center technology
companies in Royan Innovative Technologies Acceleration
and Commercialization Center (RITAC)
Research and development in antibody therapy of
Inflammatory bowel disease
Research and development in antibody therapy of
Inflammatory bowel disease
Generally the action of orally administered IgG is intended to be achieved within a specific localized site along the alimentary tract
Several mechanisms of action is proposed in host protection:
Noncommunicable diseases (NCDs) Infectious disease and pandemics Antibiotic-resistant microbes
Generally the action of orally administered IgG is intended to be achieved within a specific localized site along the alimentary tract
Several mechanisms of action is proposed in host protection:
Therapeutic Antibodies Have Become One of The Fastest Growing Classes of Drugs in Recent Years and Are Approved For the Treatment of a Wide Range of Disease
Expert R&D
Expert R&D
QC & Laboratory executive officer
Scientist
Scientist
Expert R&D
Expert R&D
